Location · Allen, TX
Clinical trials in Allen, TX
10 recruiting studies have a site in Allen, and 0 of them accept healthy volunteers.
10 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Sanofi
- Location
- Allen, TX + 72 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 3
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Vor Biopharma
- Location
- Allen, TX + 46 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
Novartis Pharmaceuticals
- Location
- Allen, TX + 8 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingPhase 3
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
EMD Serono Research & Development Institute, Inc.
- Location
- Allen, TX + 11 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With…
Ventus Therapeutics U.S., Inc.
- Location
- Allen, TX + 14 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Mediar Therapeutics
- Location
- Allen, TX + 13 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic…
AstraZeneca
- Location
- Allen, TX + 31 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
AstraZeneca
- Location
- Allen, TX + 2 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 1
A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)
Climb Bio, Inc.
- Location
- Allen, TX + 1 other US site
- Eligibility basics
- Ages 18–65
- Recruiting
ConsideRAte Study - Splenic Stimulation for RA
Galvani Bioelectronics
- Location
- Allen, TX + 9 other US sites
- Eligibility basics
- Ages 22–75